Skip to main content
Fig. 5 | Molecular Medicine

Fig. 5

From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Fig. 5

Construction and evaluation of a nomogram. ROC curves, for DFS at A 1 year, B 3 years, C 5 years, represent the sensitivity and specificity of a 19-ARG signature and the selected clinical features in predicting the prognosis of PRAD patients. D A nomogram for predicting DFS possibilities of PRAD patients. E Calibration plots revealed the agreement between the predicted outcomes and actual disease-free survival at 1, 3, and 5 years in the TCGA-PRAD cohort. F ROC curves, for DFS at 1, 3, and 5 years, represent the sensitivity and specificity of a nomogram

Back to article page